Is Taurine Cardiovascular Health Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Taurine Cardiovascular Health Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Recent experimental evidence suggests that taurine (2-aminoethanesulfonic acid) deficiency contributes to these conditions, despite taurine being classified as a conditionally essential amino acid. [Chu MHM (2026); evidence level 2] - Purpose This study aims to assess whether a 6-month oral taurine supplementation program improves blood glucose control and other health parameters among healthcare workers. [Chu MHM (2026); evidence level 2] - This modulation of calcium homeostasis has been associated with enhanced contractile function in both skeletal and cardiac muscle (). [Cheng Xiaodong (2026); evidence level 4] - A growing body of evidence has examined the effects of taurine supplementation across different dosages. [Cheng Xiaodong (2026); evidence level 4] - For example, Warnock et al reported that oral taurine supplementation at 50 mg·kgbody weight (~3.5–4.5 g) improved repeated sprint performance (). [Cheng Xiaodong (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.